Get Permission Shukla and Pebbili: Role of hyaluronic acid during periodontal therapy & post-periodontal surgeries


Introduction to Hyaluronic Acid

Hyaluronic acid (HA) is a linear polysaccharide occurring naturally in the synovial fluid, the extracellular matrix of connective tissue, and other tissues. It has several structural & physiological functions, such as tissue lubrication, regulation of osmotic pressure, growth factors interactions, and cellular/extracellular interactions. These function helps to maintain the tissue's homeostatic & structural integrity.1 Evidences on the physicochemical properties and physiological role have shown it as an ideal for medical, pharmaceutical, and cosmetic purposes.2

HA plays a vital role in migration, cell adhesion, and differentiation mediated by numerous binding proteins and cell-surface receptor CD44.3, 4 Additionally, the negative charge and substantial size of HA allow it to take in lots of water and exert pressure on the nearby tissue, producing an expansion of the extracellular space. Henceforth, HA uses a buffering action to the masticatory forces on the periodontal ligament. Additionally, it holds anti-inflammatory and bacteriostatic effects.5 It also has a major role in almost all the phases of wound treatment.6

HA enables cell migration and isolation throughout tissue regeneration. Application of exogenic HA is beneficial in experimental animals for wound healing.7, 8

In dentistry, the preliminary clinical trials on HA were conducted way back in 1997. A study by Vangelisti, Pagnacco et al. (1997) revealed that hyaluronate possesses anti-inflammatory, bacteriostatic and anti-edematous effects which can have a potential role in the treatment of gingivitis as well as periodontitis. Exogenic HA shows anti-inflammatory effects by exhausting metalloproteinases, prostaglandins, and other bioactive molecules.9 Anti-edematous effects were associated with osmotic activity. The high concentration of LMW HA has the most bacteriostatic effect as it stimulates the phagocytic activity of macrophages.It was used as an adjunct to mechanical therapy due to HA’s tissue healing properties.10 Nevertheless, it is plausible that HA could be effective in periodontal tissue regeneration as well as in periodontal disease treatment.11, 12 This review helps to more thoroughly understand the biochemical and pharmacological role of HA in post periodontal surgery.

History & Chemistry of HA

History

French scientist Portes noted that mucin from the vitreous body of eye was not the same as other mucoids in cornea and cartilage and termed it "hyalomucine" way back in 1880. However, it was only in 1934 that Meyer and Palmer isolated a polysaccharide consisting of an amino sugar and a uronic acid from bovine vitreous humor and called it Hyaluronic acid , derived from "hyaloid" and "uronic acid." 13 In 20th century, a gradual awareness about biological functions established HA’s advancement as a medicine for several therapies. The extraction of HA from animal tissues were increasingly enhanced, nonetheless had issues of contamination from microorganisms or proteins. To date, bacterial fermentation is one of the favorable methods for production of HMW Hyaluronic acid. Although, there are different sources to extract Hyaluronic acid, the variety of bacteria produces HA and stimulates bacterial fermentation. The most important pre-purification steps include centrifugation and numerous precipitations along with polar solvents, though ultrafiltration & size exclusion chromatography are the most chosen method for purification.14

Chemistry

The HA is a linear chain consisting of recurring disaccharide connected with ß 1,4-glycosidic bond. Disaccharide individually contains d-glucuronic acid and N-acetyl-d-glucosamine  connected by ß-1,4 -glycosidic bond.15 HA is negatively charged because of carboxylate groups. Thus, it forms hydrophilic salts with distinctive capacity of binding and retaining H2O, which allows tremendous viscoelasticity, biocompatibility, hygroscopic properties great and water retention capacity. Thus, it plays a role as a lubricant, water balance retention–flow-resistant regulator, space filler, and shock absorber.14

Figure 1

Characteristics of periodontitis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/1c95b948-e6ab-47b7-bda3-e4eb0728f109image1.png
Figure 2

Chemical structure of hyaluronan

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/1c95b948-e6ab-47b7-bda3-e4eb0728f109image2.png

Physical & Biological Properties of HA

HA is widely found in humans as well as in animals, which include rabbits, roosters, bovines, and bacteria. The total content of HA in human is about 15 g for a 70-kg adult. Cells are surround by HA and in the extracellular matrix (ECM) of connective tissues.16, 17

Hyaluronic acid has the following properties

  1. Hygroscopic nature: HA is highly hygroscopic in nature. After Hyaluronic acid contained into an aq. solution, Hydrogen appears among the adjacent; acetyl and carboxyl groups, which maintains conformational stiffness and retain water. It functions as physical background material in space-filling, shock absorption and lubrication.

  2. Bacteriostatic effect: Evidence on regenerative operative procedures indicates that reducing bacterial burden at the wound area improves regenerative treatment. Elevated concentration of moderate to lower MW Hyaluronic acid has the most significant bacteriostatic effect, more specifically on Prevotella oris, Aggregatibacter actinomycetemcomitans, & Staphylococcus aureus strains, which are mainly observed in periodontal as well as in gingival wounds. Use of hyaluronic acid during surgeries reduces the contamination around the wound, thus reducing the possibility of post-operative infection and fostering inevitable regeneration.18

  3. Viscoelastic properties: HA helps in periodontal regenerative processes by sustaining spaces and surfaces. The viscoelastic properties slow down the infiltration of viruses and bacteria in treating periodontal diseases.18

  4. Anti-oedematous: HA exhibits a non-ideal osmotic pressure, which improves exponentially instead of linearly with rising concentration of hyaluronan. This property provides HA osmotic buffering capacity, which possibly regulates the water content in a tissue.10

  5. Antioxidant: HA behave as an antioxidant by scavenging ROS and controls inflammatory responses. Therefore, it might help to steady the granulation tissue matrix.19

  6. Biocompatibility & non-antigenicity: The high biocompatible and non-immunogenic environment of HA results in various proven functions, such as fluid in arthriti9; and also in facilitating the regeneration/ healing of bone, periodontal tissue and surgical wounds.10

  7. Anti-inflammatory: Anti-inflammatory effect of HA is because of its exogenous role by draining metalloproteinases, prostaglandins, and other bio-active molecules.

Role of HA in healing of periodontal tissues

Healing of periodontal tissue involves phases of extremely reproducible and firmly regulated biologic events that gather and debride the wounded tissue, foreign substance, and microbial cells [Figure 1, Figure 2]. Phases ends with the growth and maturation of ECM which restores tissue endurance.20, 21

  1. Inflammatory phase: In the early stages of inflammation, HA plays a number of tasks. For example, it interacts with the fibrin clot to provide structural support, which controls the infiltration and ECM into the inflammatory area. According to Hakansson et al. HA in adherence and migration of macrophages and polymorphonuclear leukocytes at the inflamed region, phagocytosis & destroying invasive microbes. Such events would agree to lessen the colonization and proliferation of anaerobic pathogen in gingival crevice & nearby periodontal tissues.22 HA also inhibit periodontal pathogen colonization by directly preventing microbial proliferation. HA produces proinflammatory cytokines by fibroblasts,osteoblasts, cementoblasts and keratinocytes which boost the inflammatory response & subsequently promote HA production by endothelial cells. It indirectly acts to lessen the inflammation & alleviate the granulation tissue through blocking degradation of the ECM proteins by serine proteinases obtained from inflammatory cells as healing continues.23, 24

  2. Granulation phase & re-epithelization: HA stimulates proliferationof cell, converts matrix cells into granulation tissue matrix. Hyaluronic acid in mineralized tissues progressively switched by a temporary mineralized callus.25, 26 During late granulation phase, existing HA is depolymerized by hyaluronidases instigating the development of LMW HA & an modification in the composition of the granulation tissue. LMW HA fragments produce after hyaluronidase action stimulate the production of angiogenesis inside wound area.27

  3. Bone regeneration: HA increase bone regeneration due to proliferation, chemotaxis and variation of mesenchymal cells. Hayaluronic acid shares bone induction qualities with osteopontin and bone morpho genetic protein 2.28, 29

Figure 3

Phases of periodontal healing

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/8fd09639-36da-4bad-90a9-9b8eaeea4184/image/b3fe8137-4d9b-4598-95bb-cbe3f39c2e3a-uimage.png

Studies of HA in periodontal tissue healing and regeneration

Studies based on the use of HA in post peridontal surgery, gingivitis, peridontitis were included. Clinical studies were searched in Google Scholar and PubMed using keywords ("hyaluronic acid" and "post-periodontal surgery"), ("hyaluronic acid" and "periodontitis"), ("hyaluronic acid" and "gingivitis").

HA in gingivitis

HA has emerged as a beneficial adjuvant in the management of gingivitis. Jentsch et al. 2003 revealed that 0.2% HA twice daily for three weeks is effective in patients affected by gingivitis, improvise PI, PBI, and GCF.30 Pistorius et al. 2005 also showed that HA reduces SBI, PBI values, and GCF. 31 Likewise, Sahayata et al.2014 revealed that g,0.2% HA gel in inflamed gingiva for four weeks adjunctly with oral hygiene & scaling resulted in significant improvement in the GI and PBI.32

Table 1

Overview of clinical trials

Type of study

Interventions

N

Duration

Results

Ref

Gingivitis

RCT

25 patients with 0.2% HA gel or placebo

50 male patients

21 days

HA group had great improvement for the PI and papilla bleeding index beginning with day 7. CF variables had significant improvement in the center of the inflammation area

30

RCT

40 patients used a spray containing HA and 20 patients used placebo 5 times daily for 1 week.

60 patients with clinical signs of gingivitis

1 week

Decrease in the SBI in the HA group was observed at T2 and at T3. The PBI values and the GCF decreased in the HA group

31

RCT

Negative control group: scaling, placebo control group: scaling + placebo gel test group: scaling+ 0.2 % HA twice daily for a 4 week

105 chronic plaque induce gingivitis

4 weeks

Significant variation in GI and PBI in HA group

32

Chronic periodontitis

RCT

HA gel or placebo twice a day for 1 month

21

30 days

HA reduced proliferation index of the gingival epithelium and fibroblastic cells

33

RCT

HA gel administered subgingival

12 patients with chronic periodontitis

12 weeks

Lower bleeding on probing scores in the HA group at 12 weeks (P <0.05). Mean probing depth reductions at 12 weeks (1.0 +/- 0.3 mm.)

34

RCT

0.2 mL of 0.8% HA with SRP and after one week

18 patients moderate to severe chronic periodontitis

2 weeks

Reduction in BOP, API, PPD, CFUs and CAL in the test sites than control group.

35

RCT

1 mL of 0.2% HA gel or placebo at baseline and at the end of weeks 1, 2, and 3.

26 patients with chronic periodontitis

12 weeks

The test sites showed statistically significant improvement in GI and BI at 6 and 2 weeks than control sites

36

RCT

0.2% HA gel or placebo after SRP and 1 week post treatment

33 patients with chronic periodontitis

12 weeks

In the HA group, this combined treatment showed a significant improvement in all clinical parameters: BOP, PPD, and CAL, at 12 weeks post therapy in comparison to the control group treated with SRP only

37

RCT

Patients received 0.5 mL of amino acids and HA gel or 0.5 mL of placebo gel

11 patients with moderate-severe chronic periodontitis

90 days

HA showed significant reduction in probing depth and bleeding on probing than control group.

38

RCT

16 mg/mL of cross-linked and 2 mg/mL of non-cross-linked HA or placebo

100

3 months

HA in periodontal therapy decreased in inflammation, measured by bleeding on probing by 6% compared to the control group and gain in periodontal attachment,1 mm more than control group.

39

Post-Periodontal Surgery

Comparative Study

N=19 defects

Esterified HA (fibers packed in periodontal defects)

One year post study

PPD reduced, gingival recession increased, and CAL gain.

40

RCT

Sites treated with hyaluronic acid) and treated with open flap debridement (control group).

40 patients with a two-wall infrabony defect

During the surgery

The treatment of infrabony defects with HA showed additional benefit in gCAL , probing depth reduction, and predictability compared to open flap debridement

41

RCT pilot study

Esterified form of HA gel

19 adult patients with mild chronic periodontitis and shallow pockets

3 weeks

BOP in the HA group reduce 92.7% and GI of 96.5%. The difference of PPD in both areas was statistically significant (p<0.01) in favour of the HA gel treated zone.

42

RCT

16 mg/mL cross-linked HA and 2 mg/mL non-cross-linked HA.5 mL of 0.8% HA gel or placebo

100 patients with moderate periodontitis

3 months

There was a significant reduction in inflammation, measured by bleeding on probing (−6% compared to the control group) and gain in periodontal attachment (1 mm more than control group)

43

Clinical trial

Esterified low-molecular HA preparation (EHA)

9 patients with periodontal defects

Follow up study (10 days, 6, 9 & 24 months)

Clinical results showed gCAL gain of 2.6 mm at the treated area.

44

HA in chronic periodontitis

The HA gel decreases cell proliferation in epithelial cells including lymphocytes, fibroblasts and subsides the inflammatory response and periodontal lesion in chronic periodontitis.33 Johannsen et al.2009 noted that twice subgingival administrations of 0.8% Hyaluronic acid gel reduce bleeding in the treatment group.34 Comparably, Polepalle et al.,2015 demonstrated that application of 0.8% Hyaluronic acid gel for seven days, reduced the BOP, plaque index, PPD, CAL, and CFU.35 Gontiya et al., 2012 noted that application of 0.2 % Hyaluronic acid gel with Scaling & root planning (SRP) in chronic periodontitis patients improved the GI and BI and decreased in inflammatory infiltrate.36

Rajan et al. 2014 showed that Hyaluronic acid application directly after Scaling & root planning and seven days post therapy is effective in chronic periodontitis. Combined treatment demonstrated a considerable progress in all clinical parameters: BOP, PPD, and CAL, at 12 weeks post-therapy compared with SRP alone.37

Bevilacqua et al.2012 showed that 0.5 mL of amino acids and HA gel subsequent to ultrasonic mechanical instrumentation reduced PPD and BOP in moderate to severe chronic periodontitis in comparison to ultrasonic debridement alone.38

HA in post-periodontal surgery

El-Sayed et al. 2012 evaluated the clinical impact of hyaluronan gel (0.8%) in combination with periodontal surgery. Substantial improvement (P < 0.05) was observed in the treatment and the control site after 3 & 6 months. The treatment site displayed greater improvement in clinical attachment level (CAL) & reduction in gingival recession (GR).39 Leonardo et al. 2009 examined the clinical efficiency of esterified HA for periodontal imperfections. During the study, nineteen defects (one mandibular molar and eighteen infrabony furcation) were treated using hyaluronic acid fibers. One year treatment displayed 5.8 mm reduction in the mean probing pocket depth (PPD) and 3.8 mm benefit in the attachment.40 Briguglio et al.2013 investigated the use of HA for the treatment of infrabony periodontal defects. The mean CAL gain of 1.9 ± 1.8 mm, was obtained with PD reduction of 1.6 ± 1.2 mm.41 Pilloni et al. 2012, assessed the benefit of hyaluronic acid gel on periodontal considerations. Study results that HA gel has an effect in alleviating the inflammation of gingival and increase the periodontal CI.42 Olszewska-Czyz et al. 2021 suggested that HA has greater gain in clinical attachment and reduced bleeding on probing, which indicates reduced inflammation and periodontal regeneration.43 According to Ballini et al. 2009, HA has good abilities for regeneration of bone in infrabony defects.44

Abbreviations: papillary bleeding index -PBI, and gingival crevicular fluid-GCF, sulcus bleeding index -SBI gingival index -GI, bleeding on probing- BOP, plaque index — PI, bleeding on probing pocket depth -PPD, clinical attachment level-CAL, and colony-forming units-CFUs, bleeding index-BI, probing pocket depth-PPD

To summarize, Hyaluronic Acid is broadly used in several branches of medicine with potential use in dentistry to treat inflammatory diseases. In the periodontium, hyaluronic acid is present in smaller amount in mineralized tissues while abundant in non-mineralized tissues.

While SRP is the first step in the management of periodontal diseases, use of adjuvants along with antibiotics has been advocated in multiple clinical studies in the past. Hyaluronic acid, due to its multi-functional role has emerged as a potential adjuvant along with SRP to help improve the clinical parameters in re-gaining periodontal health.

The periodontal wound healing comprises sequence of reproducible & firmly controlled biological actions, including inflammation, epithelium formation, granulation tissue formation & tissue remodeling. During the inflammatory phase, it forms a structural framework by interacting with fibrin clot and helps to prevent pathogen colonization by directly preventing microbial proliferation. In the granulation phase, HA stimulates proliferation of cells, movement of matrix cells into granulation tissue matrix. The fragments formed due to HA also helps to boost the development of blood vessels (angiogenesis) in wound sites. Furthermore, Hyaluronic acid speeds up rejuvenation of bone by proliferation, chemotaxis and isolation of mesenchymal cells.

Conclusion

It is evident from the various clinical studies that local application of HA has a multifactorial function in the treatment of chronic periodontitis and even after post-periodontal surgery for the repair and regeneration of periodontal tissues and alveolar bone. Due to its versatile nature and exceptional physicochemical properties, HA has been used in various forms and concentrations and has reported favorable clinical outcomes as seen in different clinical studies which further confirm HA's beneficial effects in wound healing and tissue regeneration.

Source of Funding

None.

Conflict of Interest

None.

Acknowledge

We acknowledge IntelliMed Healthcare Solutions LLP, Mumbai, India, for medical writing support.

References

1 

A Ialenti D Rosa Hyaluronic acid modulates acute and chronic inflammationAgents Actions1994431-24451

2 

P Dahiya R Kamal Hyaluronic Acid: a boon in periodontal therapyN Am J Med Sci20135530924

3 

O Oksala T Salo R Tammi L Häkkinen M Jalkanen P Inki Expression of proteoglycans and hyaluronan during wound healingJ Histochem Cytochem199543212560

4 

TC Laurent JR Fraser HyaluronanFASEB J1992672397404

5 

P Pirnazar L Wolinsky S Nachnani S Haake A Pilloni GW Bernard Bacteriostatic effects of hyaluronic acidJ Periodontol19997043704

6 

PH Weigel GM Fuller RD Leboeuf A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healingJ Theor Biol1986119221953

7 

G Abatangelo M Martelli P Vecchia Healing of hyaluronic acid-enriched wounds: histological observationsJ Surg Res19833554106

8 

SR King WL Hickerson KG Proctor Beneficial actions of exogenous hyaluronic acid on wound healingSurgery199110917684

9 

TC Laurent UB Laurent JR Fraser Functions of hyaluronan in wound repairWound Rep Regen199554542961

10 

H Jentsch R Pomowski G Kundt R Göcke Treatment of gingivitis with hyaluronanJ Clin Periodontol200330215964

11 

G Embery WM Oliver JB Stanbury JA Purvis The electrophoretic detection of acidic glycosaminoglycans in human gingival sulcus fluidArch Oral Biol198227217786

12 

MA Pogrel MA Lowe R Stern Hyaluronan (hyaluronic acid) in human salivaArch Oral Biol199641766771

13 

CG Boeriu J Springer FK Kooy LV Den Broek G Eggink Production Methods for HyaluronanInt J Carbohydrate Chem201362496711410.1155/2013/624967

14 

CD Rodriguez-Marquez S Arteaga-Marin AR -Sánchez RA Hernández R Castro-Muñoz A Review on Current Strategies for Extraction and Purification of Hyaluronic AcidInt J Mol Sci20222311603810.3390/ijms23116038

15 

HK Marques M Pravda L Wolfova V Velebny P Schaaf NE Vrana Hyaluronic Acid and Its Derivatives in Coating and Delivery Systems: Applications in Tissue Engineering, Regenerative Medicine and ImmunomodulationAdv Healthc Mater2016522284155

16 

N Volpi J Schiller R Stern Role, Metabolism, Chemical Modifications and Applications of HyaluronanCur Med Chem1998161416

17 

L Balogh A Polyak D Mathe R Kiraly J Thuroczy M Terez Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogsJ Agric Food Chem200856221058293

18 

I W Sutherland Novel and established applications of microbial polysaccharidesTrends Biotechnol1998161416

19 

RJ Waddington R Moseley G Embery Reactive oxygen species: a potential role in the pathogenesis of periodontal diseasesOral Dis20006313851

20 

WY Chen G Abatangelo Functions of hyaluronan in wound repairWound Repair Regen1999727989

21 

R Moseley RJ Waddington G Embery Hyaluronan and its potential role in periodontal healingDent Update200229314452

22 

L Håkansson R Hällgren P Venge Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolismJ Clin Invest1980662298305

23 

HG Wisniewski J Vilcek TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activityCytokine Growth Factor Rev19978214356

24 

H Larjava J Heino VM Kähäri T Krusius E Vuorio Characterization of one phenotype of human periodontal granulation-tissue fibroblastsJ Dent Res1989681205

25 

B Pm P Rc The effect of chronic inflammation on gingival connective tissue proteoglycans and hyaluronic acidJ Oral Pathol19861576747https://pubmed.ncbi.nlm.nih.gov/3098943/

26 

PM Bartold RC Page The effect of chronic inflammation on gingival connective tissue proteoglycans and hyaluronic acidJ Oral Pathol198615736774

27 

SL Ruggiero CN Bertolami RE Bronson PJ Damiani Hyaluronidase activity of rabbit skin wound granulation tissue fibroblastsJ Dent Res198766712837

28 

RM Mendes G Silva MF Lima MV Calliari AP Almeida JB Alves Sodium hyaluronate accelerates the healing process in tooth sockets of ratsArch Oral Biol20085312115562

29 

R Deed P Rooney P Kumar JD Norton J Smith AJ Freemont Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronanInt J Cancer19977122516

30 

H Jentsch R Pomowski G Kundt R Göcke Treatment of gingivitis with hyaluronan: Gingivitis treatment with hyaluronanJ Clin Periodontol200330215964

31 

A Pistorius B Willershausen The clinical application of hyaluronic acid in gingivitis therapyQuintessence Int2005367-85318

32 

VN Sahayata NV Bhavsar NA Brahmbhatt An evaluation of 0.2% hyaluronic acid gel (Gengigel ®) in the treatment of gingivitis: a clinical & microbiological studyOral Health Dent Manag201413377985

33 

F Mesa J Aneiros A Cabrera M Bravo T Caballero F Revelles Antiproliferative effect of topic hyaluronic acid gel. Study in gingival biopsies of patients with periodontal diseaseHistol histopathol20021734753

34 

A Johannsen M Tellefsen U Wikesjö G Johannsen Local delivery of hyaluronan as an adjunct to scaling and root planing in the treatment of chronic periodontitisJ Periodontol20098091493500

35 

T Polepalle M Srinivas N Swamy S Aluru S Chakrapani BA Chowdary Local delivery of hyaluronan 0.8% as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A clinical and microbiological studyJ Indian Soc Periodontol20151913742

36 

G Gontiya SR Galgali Effect of hyaluronan on periodontitis: A clinical and histological studyJ Indian Soc Periodontol201216218492

37 

P Rajan R Baramappa NM Rao AK Pavaluri PI Rahaman Hyaluronic Acid as an Adjunct to Scaling and Root Planing in Chronic Periodontitis. A Randomized Clinical TrailJ Clin Diagn Res2014812115

38 

L Bevilacqua J Eriani I Serroni G Liani V Borelli G Castronovo Effectiveness of adjunctive subgingival administration of amino acids and sodium hyaluronate gel on clinical and immunological parameters in the treatment of chronic periodontitisAnnali di Stomatologia2012327581

39 

F El-Sayed KM Dahaba MA Aboul-Ela S Darhous Local application of hyaluronan gel in conjunction with periodontal surgery: a randomized controlled trialClin Oral Invest2012164122965

40 

LV Bogaerde Treatment of infrabony periodontal defects with esterified hyaluronic acid: clinical report of 19 consecutive lesionsInt J Period Rest Dent200929331538

41 

F Briguglio E Briguglio R Briguglio C Cafiero G Isola Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: a randomized clinical trialQuintessence Int201344323171

42 

A Pilloni S Annibali F Dominici Di Paolo C Papa M Cassini Evaluation of the efficacy of an hyaluronic acid-based biogel on periodontal clinical parameters. A randomized-controlled clinical pilot studyAnn Stomatol201223-439

43 

I Olszewska-Czyz K Kralik J Prpic Biomolecules in Dental Applications: Randomized, Controlled Clinical Trial Evaluating the Influence of Hyaluronic Acid Adjunctive Therapy on Clinical Parameters of Moderate PeriodontitisBiomolecules20211110149110.3390/biom11101491

44 

A Ballini S Cantore S Capodiferro FR Grassi Esterified hyaluronic acid and autologous bone in the surgical correction of the infra-bone defectsInt J Med Sci2009626571



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International, which allows others to remix, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 11-01-2023

Accepted : 21-01-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.adr.2022.016


Article Metrics






Article Access statistics

Viewed: 1112

PDF Downloaded: 134



Medical Abbreviation List